Navigation Links
Osprey Pharmaceuticals Names Jack M. Anthony as CEO
Date:9/26/2007

Co-Founder Phil Coggins to Continue as President and CSO

MONTREAL and SAN FRANCISCO, Sept. 26 /PRNewswire/ -- Osprey Pharmaceuticals, Ltd., a privately held biotechnology company developing first-in-class Leukocyte Population Modulators (LPMs) for serious, chronic diseases, announced today the appointment of Jack M. Anthony to Chief Executive Officer. Dr. Philip Coggins, who previously held the position of CEO will continue as President and assume the new role of Chief Scientific Officer. Mr. Anthony will be based in San Francisco, where Osprey has located most administrative functions, while concentrating its laboratory and R&D operations in Montreal, Canada.

"I am pleased to announce that Jack will take the helm of Osprey Pharmaceuticals and assume additional responsibilities as CEO," said Philip Coggins, President and co-founder of Osprey. "Looking at the powerhouse of talent assembled at Osprey, this transition is a 'no-brainer,' and as a neurochemist I'm qualified to say that. With Jack as CEO and with the recent addition of Dr. Barbara Finck as Chief Medical Officer, we have the key individuals in place to take Osprey to the next level."

"These changes will best leverage the extensive experience and track record of the senior management team at Osprey," said Janice LeCocq, Chairman of the Board. "This time next year we expect to have the first clinical proof of concept of our LPMs in the treatment of renal disease (glomerulonephritis, or GN). By validating a new treatment modality, we expect to open up a broad array of other clinical targets, building towards clinical and commercial success."

Mr. Anthony began his career in healthcare with Baxter Healthcare and served the company for over 16 years, rising through the ranks to become Vice President in the Blood Therapy Group. In the 20 years since Baxter, he has held various senior executive positions in a number of biotechnology companies including Applied Immune Sciences
'/>"/>

SOURCE Osprey Pharmaceuticals, Ltd.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Wisconsin IT association names Gee president, CEO
4. Quintessence Biosciences names new president
5. CDW names VP to handle Berbee merger
6. NimbleGen names CFO with capital-raising past
7. Cisco names Berbee a top partner of 2005
8. Cisco names Inacom most innovative partner
9. UW-Madison medical school names new dean
10. GE Healthcare names new CEO
11. Bruker AXS names new leadership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... AudioNotch is the ... treatment. AudioNotch is pleased to announce a partnership ... in both British Columbia and Alberta, Destination Hearing ... services. AudioNotch's tinnitus treatment program is now available ... Destination Hearing clinic, patients have the detection of ...
(Date:5/22/2013)... PA (PRWEB) May 22, 2013 Envera ... as Fermentation Manager. Mr. McErlean has an extensive ... of leadership positions throughout his career. , ... are very pleased to have Mike join our team”. ... installed large scale fermentation and downstream processing ...
(Date:5/21/2013)... , May 22, 2013 ... drug-only formulation of glycopyrronium bromide designed using Prosonix, particle ... company developing a portfolio of inhaled Respiratory Medicines ... study with PSX1002 that will assess its effect on ... doses in patients with moderate to severe chronic obstructive ...
(Date:5/21/2013)... Through science fairs, workshops, kits for building optical ... organizations will continue their work to increase awareness about ... daily life with the aid of SPIE Education ... countries, are the first of two groups of recipients ... international society for optics and photonics , in 2013. ...
Breaking Biology Technology:AudioNotch Tinnitus Treatment Launches Partnership With Destination Hearing 2Envera Appoints Michael McErlean Fermentation Manager 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 2Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 3
... film or drop of liquid and the shape of the ... mathematical formula published this week in Physical Review Letters. ... important for a number of areas, including the chemical industry ... to explain how the relationship between the liquid and the ...
... its presence in Europe ... its methodological expertise., BOSTON, April 7, 2008 The ... a Director based in the United,Kingdom. Penny will work closely ... the company,s European and global,business. Penny specializes in the provision ...
... BioSpace, the world,s,leading online bioscience job board and ... Label Career Fair for Regeneron Pharmaceuticals on,Thursday, April ... the Hanover Marriott,in Whippany, New Jersey from 1 ... ), Regeneron is looking to fill ...
Cached Biology Technology:Physicists saved from drowning in complexities of wetting theory 2Observant LLC Appoints Two New Directors to the Senior Management Team 2BioSpace to Host Regeneron Pharmaceuticals Career Fair in Whippany, New Jersey 2
(Date:5/22/2013)... is responsible for legionellosis, an infectious disease that can ... pathogen has developed a complex method enabling it to ... avoiding these acting against the infectious bacteria. , Research ... in which teams from the National Institute of Health ... in Barcelona (BSC) have also participated, has described for ...
(Date:5/22/2013)... additives known as phthalates (pronounced THAL-ates) are odorless, ... in flooring, plastic cups, beach balls, plastic wrap, ... Control and Preventionthe bodies of most Americans. Once ... scrutiny. A growing collection of evidence suggests dietary ... and mix with food) may cause significant metabolic ...
(Date:5/21/2013)... shows that the nation,s land and water resources could ... up to 25 billion gallons of algae-based fuel a ... yearly needs. , The findings come from an in-depth ... to grow significant amounts of algae in large, specially ... May 7 issue of Environmental Science and Technology ...
Breaking Biology News(10 mins):Mechanism discovered which aids Legionella to camouflage itself in the organism 2Study links chemicals widely found in plastics and processed food to elevated blood pressure in children and teens 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 4
... two or more induced abortions have a reduced risk of ... what degree physical activity during pregnancy protects against pre-eclampsia, compared ... from the Norwegian Institute of Public Health (NIPH) that use ... The new results from MoBa were presented on ...
... that plants growing under unfavourable conditions are generally smaller than ... in the US, abiotic stress reduces the yield of agricultural ... the effect of stress in this case, repeated wounding ... which every aspect of their stature, including height, girth, and ...
... A team of researchers led by North Carolina State University ... devices and a host of other revolutionary medical implants. The ... material can be used to create new devices that can ... sensors for diabetics and artificial hemo-dialysis membranes that can scrub ...
Cached Biology News:Previous abortions and exercise: Do they affect pregnancy? 2Previous abortions and exercise: Do they affect pregnancy? 3The bonsai effect: Wounded plants make jasmonates, inhibiting cell division, stunting growth 2NC State finds new nanomaterial could be breakthrough for implantable medical devices 2
Mouse monoclonal antibody raised against a partial recombinant CENTB2. NCBI Entrez Gene ID = CENTB2...
... tubing prep station, 100-120 V, is used to ... gold particles to create the source of the ... with the Helios gene gun. The station includes ... prep unit, 12 foot Nalgene nitrogen regulator hose, ...
Mouse polyclonal antibody to NR2F2 - nuclear receptor subfamily 2, group F, member 2...
The Discovery Series PDQuest 2-D analysis software is used for imaging, analyzing, and databasing two-dimensional electrophoretic gels. The 10-user network license entitles ten users to access data f...
Biology Products: